Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT

Correspondence: Dr S Fuji, Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo 104-0045, Japan. E-mail: sfuji@ncc.go.jp To elucidate the impact of pretransplant body mass index on the clinical outcome, we performed a retrospective study with registry data including a total of 12 050 patients who received allogeneic hematopoietic SCT between 2000 and 2010.

http://ift.tt/1yhV9Iu